Literature DB >> 16639623

Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.

Yoshiaki Kiuchi1, Kazuto Nakae, Yoshihiro Saito, Shigeo Ito, Nami Ito.   

Abstract

BACKGROUND: Treatment of neovascular glaucoma (NVG) must be focused on the reduction of intraocular pressure (IOP) and prompt application of pan retinal photocoagulation (PRP). A combination of complete PRP during vitrectomy with trabeculectomy should theoretically be a better method to lower the IOP rapidly in eyes with NVG. The purpose of our study is to assess the efficacy of combining pars plana vitrectomy and PRP with trabeculectomy assisted by mitomycin C (MMC) on NVG eyes secondary to diabetic retinopathy.
METHODS: Twenty-five eyes with NVG associated with diabetic retinopathy had pars plana vitrectomy, followed by PRP and trabeculectomy with MMC. The eyes were divided into two groups: nine eyes with vitreous hemorrhage, fibrovascular membrane and/ or retinal detachment were placed in the Proliferation group; and 16 eyes without vitreous hemorrhage, fibrovascular membrane, or retinal detachment were placed in the PC (photocoagulation) group. These eyes had vitrectomy performed so that PRP could be safely performed from ora to ora. The surgical outcome in the two groups was assessed by Kaplan-Meier survival analysis. The criteria for success were a postoperative intraocular pressure (IOP) < or =21 mmHg and a preservation of light perception.
RESULTS: In the Proliferation group, Kaplan-Meier life-table analysis showed that the success rate was 55.6% after 1 year and 18.5% after 2 years. The success rate in the PC group was 81.2% from 1 to 3 years after surgery. The surgical outcome was significantly better in the PC group than in the Proliferation group (P=0.009). In the Proliferation group, four eyes had preoperative vitreous hemorrhage, three eyes had a fibrovascular membrane, and two eyes had a retinal detachment. Three of four eyes with vitreous hemorrhage achieved good IOP control. On the other hand, the IOP of all eyes with retinal detachment and fibrovascular membrane were not lowered significantly.
CONCLUSIONS: Complete PRP combined with trabeculectomy with MMC can effectively reduce the elevated IOP in eyes with NVG. However, this combined treatment is not effective in eyes with proliferative membranes and retinal detachments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639623     DOI: 10.1007/s00417-006-0321-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  11 in total

1.  Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma.

Authors:  K U Bartz-Schmidt; G Thumann; A Psichias; G K Krieglstein; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-12       Impact factor: 3.117

2.  Long-term results of pars plana vitrectomy combined with filtering surgery for neovascular glaucoma.

Authors:  Toshihiro Kono; Sousuke Shiga; Yoshiko Takesue; Taiji Sakamoto
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2005 May-Jun

3.  Mid-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients.

Authors:  S M Hyung; S K Kim
Journal:  Korean J Ophthalmol       Date:  2001-12

Review 4.  Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma.

Authors:  J A Sivak-Callcott; D M O'Day; J D Gass; J C Tsai
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

5.  Trabeculectomy with mitomycin. A comparative study with fluorouracil.

Authors:  Y Kitazawa; K Kawase; H Matsushita; M Minobe
Journal:  Arch Ophthalmol       Date:  1991-12

6.  Glaucoma filtering surgery with 5-fluorouracil.

Authors:  E J Rockwood; R K Parrish; D K Heuer; G L Skuta; E Hodapp; P F Palmberg; M G Gressel; W Feuer
Journal:  Ophthalmology       Date:  1987-09       Impact factor: 12.079

7.  Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up.

Authors:  G J Katz; E J Higginbotham; P R Lichter; G L Skuta; D C Musch; T J Bergstrom; A T Johnson
Journal:  Ophthalmology       Date:  1995-09       Impact factor: 12.079

8.  Fluorescein gonioangiography in diabetic neovascularisation.

Authors:  Y Ohnishi; T Ishibashi; T Sagawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

9.  5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study.

Authors:  J C Tsai; W J Feuer; R K Parrish; A L Grajewski
Journal:  Ophthalmology       Date:  1995-06       Impact factor: 12.079

10.  Neovascular glaucoma. Etiologic considerations.

Authors:  G C Brown; L E Magargal; A Schachat; H Shah
Journal:  Ophthalmology       Date:  1984-04       Impact factor: 12.079

View more
  16 in total

Review 1.  Neovascular glaucoma.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2007-08-08       Impact factor: 21.198

Review 2.  Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors:  Arathi Simha; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-10-02

3.  Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.

Authors:  Yosuke Sugimoto; Hideki Mochizuki; Hideaki Okumichi; Masaya Takumida; Michiya Takamatsu; Seiichi Kawamata; Yoshiaki Kiuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-04       Impact factor: 3.117

Review 4.  Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.

Authors:  Megan Kim; Chelsea Lee; Rachael Payne; Beatrice Y J T Yue; Jin-Hong Chang; Hongyu Ying
Journal:  Surv Ophthalmol       Date:  2015-05-15       Impact factor: 6.048

5.  The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis).

Authors:  Peter A Netland
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

6.  Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma.

Authors:  Jin-Tao Sun; Hai-Jing Liang; Meng An; Da-Bo Wang
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

7.  Long-term vision outcomes for patients with albinism and diabetic retinopathy.

Authors:  Declan C Murphy; Mohamed Katta; Catherine A Egan; Michel Michaelides; Louisa Wickham
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-24       Impact factor: 3.117

8.  Treatment outcomes in the neovascular glaucoma tube versus trabeculectomy study.

Authors:  Kana Tokumo; Kaori Komatsu; Yuki Yuasa; Yumiko Murakami; Hideaki Okumichi; Kazuyuki Hirooka; Shunsuke Nakakura; Hitoshi Tabuchi; Yoshiaki Kiuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-06-14       Impact factor: 3.117

Review 9.  Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors:  Arathi Simha; Kanza Aziz; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina B Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2020-02-06

10.  Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma.

Authors:  Christopher C Shen; Sarwat Salim; Haiming Du; Peter A Netland
Journal:  Clin Ophthalmol       Date:  2011-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.